Open Access Repository

Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid (Review)

Downloads

Downloads per month over past year

Walters, EH, Gibson, PG, Lasserson, TJ and Walters, JAE 2007 , 'Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid (Review)' , Cochrane Database of Systematic Reviews, no. 3 , pp. 1-285 , doi: 10.1002/14651858.CD001385.pub2.

[img] PDF
4395.pdf | Request a copy
Full text restricted

Abstract

Asthma is a common respiratory disease among both adults and children and short acting inhaled beta-2 agonists are used widely for
’reliever’ bronchodilator therapy. Long acting beta-2 agonists (LABA) were introduced as prospective ’symptom controllers’ in addition
to inhaled corticosteroid ’preventer’ therapy (ICS). In this updated review we have included studies in which patients were either not
on ICS as a group, or in which some patients, but not all, were on ICS to complement previous systematic reviews of studies where
LABA was given in patients uniformly receiving ICS.We have focussed particularly on serious adverse events, given previous concerns
about potential risks, especially of death, from regular beta-2 agonist use.

Item Type: Article
Authors/Creators:Walters, EH and Gibson, PG and Lasserson, TJ and Walters, JAE
Journal or Publication Title: Cochrane Database of Systematic Reviews
Publisher: John Wiley & Sons Ltd
ISSN: 1469-493X
DOI / ID Number: 10.1002/14651858.CD001385.pub2
Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP